RAC1 and osteosarcoma: Retraction: Chenglin Yang, MicroRNA‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1 2016, Vol 20, Issue 9 (https://doi.org/10.1111/jcmm.12852).